Samsung Biologics Reports Operating Profit of 91.7 Billion KRW Last Year, Up 64.6% YoY

[Asia Economy Reporter Song Seung-yoon] Samsung Biologics announced on the 22nd that its operating profit last year was 91.7 billion KRW, an increase of 64.6% compared to 2018.

During the same period, sales revenue rose 30.9% to 701.6 billion KRW. On the other hand, net profit decreased by 9.5% to 202.9 billion KRW.